Press releases
-
December
07
BOTANECO’S NATURAL OLEOSOME BASED SUNSCREENS MEET NEW FDA REQUIREMENTS
QUEBEC CITY, QC – December 7, 2011 – Botaneco Corp. (“Botaneco” or the “Corporation”) (TSX-V:BOT), announces that several of its natural and traditional Hydresia? oleosome sunscreen prototypes have successfully completed the necessary testing required to meet the new U.S. Food and Drug Administration (FDA) requirements for sunscreen labeling that go into effect in 2012. The testing included a successful “critical wavelength” study which will allow sunscreen marketers utilizing Botaneco’s Hydresia? oleosomes to be labeled “Broad Spectrum” indicating protection against both ultraviolet A (UVA) and ultraviolet B (UVB) rays. Current labeling requirements on sunscreens deal almost exclusively with protection against sunburn, which is primarily caused by UVB radiation from the sun, and do not address UVA radiation, which contributes to skin cancer and early skin aging.
-
November
29
BOTANECO ANNOUNCES SENIOR MANAGEMENT CHANGE
BOTANECO ANNOUNCES SENIOR MANAGEMENT CHANGE
TSX VENTURE EXCHANGE: BOT For immediate release
QUEBEC CITY, QUEBEC – November 29, 2011 – Botaneco Corp. ("Botaneco" or the "Corporation") (TSX Venture Exchange: BOT), announces that effective immediately Mr.Aki Georgacacos has been appointed President and Chief Executive Officer (CEO), replacing Mike Stangel. Mr. Georgacacos is a member of the Botaneco’s Board of Directors and a Partner in Avrio Ventures, Canada’s largest agriculture and agritech focused venture capital fund. Mr. Georgacacos will act as President and CEO on an interim basis while the Corporation evaluates alternatives to fill the role on a permanent basis.
-
October
26
BOTANECO ANNOUNCES STOCK OPTION GRANTS AND PROVIDES CORPORATE UPDATE
TSX VENTURE EXCHANGE: BOT For immediate release
QUEBEC CITY, QUEBEC – October 26, 2011 – Botaneco Corp. (“Botaneco” or the “Corporation”) (TSX Venture Exchange: BOT), formerly known as Advitech Inc, announces that it has granted today a total of 200,000 stock options to Sectorspeak Inc, its investor relations provider.Each stock option allows the holder thereof to acquire one common share of Botaneco until October 26, 2016 for a price of $0.10 per share. The options are governed by the stock option plan of the Corporation and will vest over a one year period at a rate of 25% per quarter.
The common shares of Botaneco, further to the completion of the merger transaction with Natunola Health Biosciences Inc. (“Natunola”), consolidation of its issued and outstanding common shares (the “Consolidation”) on the basis of four pre-Consolidation shares for every one post-Consolidation share and change of its name from “Advitech Inc.” to “Botaneco Corp.” on October 7, 2011, are now trading on the TSX Venture Exchange under the “BOT” symbol. The Natunola common shares have been delisted from the TSX-V and Natunola continues its activities as a wholly-owned subsidiary of the Corporation.
-
October
07
ADVITECH AND NATUNOLA ANNOUNCE COMPLETION OF MERGER, PRIVATE PLACEMENT AND CHANGE OF NAME TO BOTANECO
QUEBEC CITY, QUEBEC AND WINCHESTER, ONTARIO – October 7, 2011 – Botaneco Corp., formerly known as Advitech Inc., ("the?"Corporation") and Natunola Health Biosciences Inc. ("Natunola") are pleased to announce the closing today of their previously announced merger transaction (the?"Transaction") and concurrent private placement for aggregate gross proceeds of $3,520,000 (the "Private Placement"). The Corporation also announces the consolidation of its issued and outstanding common shares (the?"Consolidation") on the basis of four pre-Consolidation shares for every one post-Consolidation share and the change of its name from "Advitech Inc." to "Botaneco Corp." (the "Change of Name"). The common shares of the Corporation will be trading under the "BOT" symbol further to the Transaction while the Natunola common shares will be delisted from the TSX-V and Natunola will continue its activities as a wholly-owned subsidiary of the Corporation.
-
September
30
ADVITECH AND NATUNOLA ANNOUNCE ANTICIPATED CLOSING DATE FOR THEIR MERGER
TSX VENTURE EXCHANGE: AVI and NHI For immediate release
QUEBEC CITY, QUEBEC AND WINCHESTER, ONTARIO – September 30, 2011 - Advitech Inc. ("Advitech" or the?"Corporation") (TSX Venture Exchange: AVI) and Natunola Health Biosciences Inc. ("Natunola") (TSX Venture Exchange: NHI) are pleased to announce that all conditions precedent for the completion of their proposed merger transaction (the?"Transaction") under the terms of the merger agreement entered into between Advitech and Natunola on June 29, 2011, including closing of a private placement with minimum aggregate gross proceeds of at least $3,500,000 are currently expected to be fulfilled on or around October 7, 2011 since confirmations of subscriptions totalling at least $3,500,000, the minimum amount required to complete the concurrent private placement, have been received. Advitech and Natunola therefore anticipate completion of the Transaction on or around that date subject to the satisfaction of all necessary regulatory approvals and other closing conditions.
-
September
16
ADVITECH AND NATUNOLA ANNOUNCE CHANGES TO THE TERMS OF PROPOSED PRIVATE PLACEMENT
QUEBEC CITY, QUEBEC AND WINCHESTER, ONTARIO – September 16, 2011 - Advitech Inc. (“Advitech” or the “Corporation”) (TSX Venture Exchange: AVI) and Natunola Health Biosciences Inc. (“Natunola”) (TSX Venture Exchange: NHI) announce changes to the terms of the previously announced proposed private placement, which is a condition precedent to the completion of their proposed merger transaction (the “Transaction”) under the terms of the merger agreement entered into between Advitech and Natunola on June 29, 2011.
Read more in the attached Press Release.
-
September
01
Advitech Retains Investor Relations Firm
Quebec City, Quebec – September 1, 2011 - Advitech Inc. (TSX-V: AVI), a health sciences and technology company, today announced that it has retained SectorSpeak Inc. to provide strategic investor relations and communications services. SectorSpeak, owned and operated by Mr. Hogan Mullally, is a Winnipeg based capital markets consulting firm focused on the technology, clean tech, and health sciences sectors.
Under the terms of the agreement, Advitech will pay SectorSpeak a monthly fee of $6,000. Advitech has also granted SectorSpeak 200,000 stock options today (the “Initial Options”) and will grant 200,000 options (the “Additional Options”) at a date following the closing of the Company’s proposed financing and share consolidation as announced on June 30, 2011.
Each Initial Option allows the holder thereof to acquire one common share of Advitech until September 1, 2016 for a price of $0.10 per share. The Additional Options will be priced at or around the market price at that time in compliance with the policies of the TSX Venture Exchange. The Initial and Additional Options are governed by the stock option plan of the Company and will vest over a one year period and will vest at a rate of 25% per quarter. The initial contract term is 12 months and commences immediately.
Read more in the attached Press Release.
-
August
04
Natunola Shareholders Approve Merger Transaction With Advitech. Advitech Shareholders Also Approve Ancillary Matters To The Proposed Transaction
QUEBEC CITY AND WINCHESTER, ON, Aug. 4, 2011 /CNW/ - Advitech Inc. ("Advitech") (TSXV: AVI) and Natunola Health Biosciences Inc. ("Natunola") (TSX Venture Exchange: NHI) are pleased to announce that, during a special shareholders' meeting held on August 3, 2011, the shareholders of Natunola approved the resolutions authorizing the conclusion of a transaction with Advitech, namely the continuation of the corporation from the Business Corporations Act (Alberta) to the Canada Business Corporations Act and the resolutions authorizing the amalgamation of Natunola with 7894716 Canada Inc., a wholly owned subsidiary of Advitech (the "Amalgamation").
During a special shareholders' meeting of Advitech held on the same day, the Advitech shareholders conditionally approved the election of Dr. Nam Fong Han and Mr. David Edwards to the board of directors of Advitech, as well as other ancillary resolutions to the Amalgamation, namely the proposed change of name of Advitech Inc. to "Botaneco Corp." following the closing of the amalgamation, and the consolidation of all outstanding common shares of Advitech on a 4:1 basis, immediately following the closing of the Amalgamation.
Read more in the attached Press Release.
-
July
18
BOTANECO ANNOUNCES TECHNICAL ADVANCEMENTS IN LOADING OF HYDRESIA® OLEOSOMES
Quebec City, Quebec – July 18, 2011 – Advitech Inc.’s (TSX Venture Exchange: AVI) subsidiary Botaneco Specialty Ingredients Inc (“Botaneco”) today announced a breakthrough in the development of its proprietary Hydresia® Oleosome technologies for loading, protecting and delivery of active ingredients used in personal care, by its Research and Development (R&D) facility based in Bensalem, Pennsylvania USA.The Company has demonstrated that Hydresia® Oleosomes can be loaded with a wide variety of oil soluble materials including vitamins, oils, fragrances and anti-aging actives. Key benefits are expected to be the delayed release of actives on the skin or hair for improved performance, lower irritation potential and increased stability. The Company has recently achieved 40% loading of retinol, an unstable anti-aging active and has previously announced that sunscreen formulations using oleosomes exhibited greatly enhanced SPF and UVA protection. The ability to load, protect and deliver unstable active ingredients is anticipated, in the opinion of the Company, to allow expanded applications and higher margin new business.
Botaneco is actively collaborating with multinational customers, fragrance manufacturers and distribution partners to advance the loading properties of Hydresia® Oleosomes as it pertains to a variety of oil soluble materials. The Company intends to protect the intellectual property covering these discoveries and methods for optimizing loading to complement its current patent portfolio.
“We believe that Hydresia® Oleosomes have already been demonstrated to be powerful, mass market emulsifiers with proven sunscreen enhancement benefits in traditional SPF products. This recent technical advancement in loading should, in our opinion, pave the way to increase interest in this technology for anti-aging, bath and body care and prestige products in both natural and traditional markets” noted Botaneco’s Vice President of R&D, Dr. Jack Guth.
Read more in the attached Press Release.
-
July
14
ADVITECH’S SUBSIDIARY BOTANECO ANNOUNCES HYDRESIA® OLEOSOME SUNSCREEN ENHANCEMENT ACHIEVES GLOBAL VERIFICATION
Quebec City, Quebec – July 14, 2011 – Advitech Inc (TSX Venture Exchange: AVI) through its subsidiary Botaneco Specialty Ingredients Inc. (“Botaneco”) is pleased to announce that previously reported sunscreen enhancement results of Hydresia® oleosomes have been further supported through the completion of new international in-vivo sunscreen studies. Botaneco’s oleosome SPF30 prototype, with only 2.5% total sunscreen chromophores, has now completed both the FDA monograph SPF testing and International SPF testing with excellent correlation between the studies’ results. The International SPF method is the approved protocol in Europe and Japan, and these results are an important step in the Hydresia® oleosome technology achieving worldwide acceptance in SPF enhancement. Furthermore, UVA testing was performed under the widely-accepted Japan Cosmetic Industry Association (JCIA) method, which also correlated well with previous reported UVA results.
"The results of these new global studies reinforce our previous sunscreen enhancement findings based on FDA methods. We anticipate this will provide further interest in Hydresia® oleosomes, particularly in global markets like Europe and Japan” noted Advitech President and CEO Michael Stangel.
Botaneco’s Vice President of R&D, Dr. Jack Guth, added that “This places Hydresia® oleosomes in an excellent position — not only does this technology allow us to achieve high levels of SPF enhancement with traditional sunscreen formulations, but it also opens the door in daily wear products such as skin lighteners, exfoliants and moisturizers. We are actively working with customers all over the world today, and look forward to having Hydresia® oleosome technology as a key component in next-generation SPF products in the coming years.”
Read more in the attached Press Release.
